No Dopamine Agonist Modulation of Brain [18F]FEOBV Binding in Parkinson’s Disease
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.1c00961
Abstract: The [18F]fluoroethoxybenzovesamicol ([18F]FEOBV) positron emission tomography (PET) ligand targets the vesicular acetylcholine transporter. Recent [18F]FEOBV PET rodent studies suggest that regional brain [18F]FEOBV binding may be modulated by dopamine D2-like receptor agents. We examined associations… read more here.
Keywords: feobv; disease; brain 18f; feobv binding ... See more keywords